Sorrento’s Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants
Sorrento Therapeutics Inc (NASDAQ:SRNE) announced the publication of a preprint entitled “Chimeric mRNA based COVID-19 vaccine induces protective immunity against Omicron…